Fisetin promotes osteoblast differentiation and osteogenesis through GSK-3β phosphorylation at Ser9 and consequent β-catenin activation, inhibiting osteoporosis-Reference-Cited by-同舟云学术

Fisetin promotes osteoblast differentiation and osteogenesis through GSK-3β phosphorylation at Ser9 and consequent β-catenin activation, inhibiting osteoporosis

Published:2021-10 Issue: Volume:192 Page:114676
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Molagoda Ilandarage Menu Neelaka,Kang Chang-Hee,Lee Mi-Hwa,Choi Yung Hyun,Lee Chang-Min,Lee Seungheon,Kim Gi-Young

Funder

National Research Foundation of Korea

Jeju National University

Kementerian Pendidikan Malaysia

Ministry of Environment

Korea Environmental Industry and Technology Institute

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference41 articles.

1. Sanggenon C Stimulates osteoblastic proliferation and differentiation, inhibits osteoclastic resorption, and ameliorates prednisone-induced osteoporosis in zebrafish model;Wang;Molecules,2018

2. The biology of normal bone remodelling;Katsimbri;Eur. J. Cancer Care (Engl.),2017

3. Disorders of bone remodeling;Feng;Annu. Rev. Pathol.,2011

4. Osteoporosis: Current concepts;Akkawi;Joints,2018

5. Osteoporosis in the European Union: Mmedical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA);Hernlund;Arch. Osteoporos,2013

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The bone nonunion microenvironment: A place where osteogenesis struggles with osteoclastic capacity;Heliyon;2024-05

2. Insights and implications of sexual dimorphism in osteoporosis;Bone Research;2024-02-18

3. miR-557 inhibits hepatocellular carcinoma progression through Wnt/β-catenin signaling pathway by targeting RAB10;Aging;2024-02-15

4. Recent advances in senescence-associated secretory phenotype and osteoporosis;Heliyon;2024-02

5. 2,4′-Dihydroxybenzophenone Exerts Bone Formation and Antiosteoporotic Activity by Stimulating the β-Catenin Signaling Pathway;ACS Pharmacology & Translational Science;2024-01-19